Placebo Effect Characteristics Observed in a Single, International, Longitudinal Study in Huntington's Disease
Identifieur interne : 001025 ( Main/Exploration ); précédent : 001024; suivant : 001026Placebo Effect Characteristics Observed in a Single, International, Longitudinal Study in Huntington's Disease
Auteurs : Esther Cubo [Espagne] ; Miguel Gonzalez [Espagne] ; Inés Del Puerto [Espagne] ; Justo Garcia De Yebenes [Espagne] ; Olga Fernández Arconada [Espagne] ; José Maria Trejo Gabriel Y Galan [Espagne]Source :
- Movement disorders [ 0885-3185 ] ; 2012.
Descripteurs français
- Pascal (Inist)
English descriptors
Abstract
Background: Classically, clinical trials are based on the placebo-control design. Our aim was to analyze the placebo effect in Huntington's disease. Methods: Placebo data were obtained from an international, longitudinal, placebo-controlled trial for Huntington's disease (European Huntington's Disease Initiative Study Group). One-hundred and eighty patients were evaluated using the Unified Huntington Disease Rating Scale over 36 months. A placebo effect was defined as an improvement of at least 50% over baseline scores in the Unified Huntington Disease Rating Scale, and clinically relevant when at least 10% of the population met it. Results: Only behavior showed a significant placebo effect, and the proportion of the patients with placebo effect ranged from 16% (first visit) to 41 % (last visit). Nondepressed patients with better functional status were most likely to be placebo-responders over time. Conclusions: In Huntington's disease, behavior seems to be more vulnerable to placebo than overall motor function, cognition, and function.
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000220
- to stream PascalFrancis, to step Curation: 002A94
- to stream PascalFrancis, to step Checkpoint: 000098
- to stream Main, to step Merge: 001077
- to stream Main, to step Curation: 001025
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Placebo Effect Characteristics Observed in a Single, International, Longitudinal Study in Huntington's Disease</title>
<author><name sortKey="Cubo, Esther" sort="Cubo, Esther" uniqKey="Cubo E" first="Esther" last="Cubo">Esther Cubo</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Hospital General Yagüe</s1>
<s2>Burgos</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<wicri:noRegion>Burgos</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gonzalez, Miguel" sort="Gonzalez, Miguel" uniqKey="Gonzalez M" first="Miguel" last="Gonzalez">Miguel Gonzalez</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Mathematics, University of Extremadura</s1>
<s2>Badajoz</s2>
<s3>ESP</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<wicri:noRegion>Badajoz</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Del Puerto, Ines" sort="Del Puerto, Ines" uniqKey="Del Puerto I" first="Inés" last="Del Puerto">Inés Del Puerto</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Mathematics, University of Extremadura</s1>
<s2>Badajoz</s2>
<s3>ESP</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<wicri:noRegion>Badajoz</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="De Yebenes, Justo Garcia" sort="De Yebenes, Justo Garcia" uniqKey="De Yebenes J" first="Justo Garcia" last="De Yebenes">Justo Garcia De Yebenes</name>
<affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Tissue Bank for Neurological Research, Ramon y Cajal, University Hospital</s1>
<s2>Madrid</s2>
<s3>ESP</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Arconada, Olga Fernandez" sort="Arconada, Olga Fernandez" uniqKey="Arconada O" first="Olga Fernández" last="Arconada">Olga Fernández Arconada</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Hospital General Yagüe</s1>
<s2>Burgos</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<wicri:noRegion>Burgos</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Trejo Gabriel Y Galan, Jose Maria" sort="Trejo Gabriel Y Galan, Jose Maria" uniqKey="Trejo Gabriel Y Galan J" first="José Maria" last="Trejo Gabriel Y Galan">José Maria Trejo Gabriel Y Galan</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Hospital General Yagüe</s1>
<s2>Burgos</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<wicri:noRegion>Burgos</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">12-0198679</idno>
<date when="2012">2012</date>
<idno type="stanalyst">PASCAL 12-0198679 INIST</idno>
<idno type="RBID">Pascal:12-0198679</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000220</idno>
<idno type="wicri:Area/PascalFrancis/Curation">002A94</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000098</idno>
<idno type="wicri:doubleKey">0885-3185:2012:Cubo E:placebo:effect:characteristics</idno>
<idno type="wicri:Area/Main/Merge">001077</idno>
<idno type="wicri:Area/Main/Curation">001025</idno>
<idno type="wicri:Area/Main/Exploration">001025</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Placebo Effect Characteristics Observed in a Single, International, Longitudinal Study in Huntington's Disease</title>
<author><name sortKey="Cubo, Esther" sort="Cubo, Esther" uniqKey="Cubo E" first="Esther" last="Cubo">Esther Cubo</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Hospital General Yagüe</s1>
<s2>Burgos</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<wicri:noRegion>Burgos</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gonzalez, Miguel" sort="Gonzalez, Miguel" uniqKey="Gonzalez M" first="Miguel" last="Gonzalez">Miguel Gonzalez</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Mathematics, University of Extremadura</s1>
<s2>Badajoz</s2>
<s3>ESP</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<wicri:noRegion>Badajoz</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Del Puerto, Ines" sort="Del Puerto, Ines" uniqKey="Del Puerto I" first="Inés" last="Del Puerto">Inés Del Puerto</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Mathematics, University of Extremadura</s1>
<s2>Badajoz</s2>
<s3>ESP</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<wicri:noRegion>Badajoz</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="De Yebenes, Justo Garcia" sort="De Yebenes, Justo Garcia" uniqKey="De Yebenes J" first="Justo Garcia" last="De Yebenes">Justo Garcia De Yebenes</name>
<affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Tissue Bank for Neurological Research, Ramon y Cajal, University Hospital</s1>
<s2>Madrid</s2>
<s3>ESP</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<placeName><settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Arconada, Olga Fernandez" sort="Arconada, Olga Fernandez" uniqKey="Arconada O" first="Olga Fernández" last="Arconada">Olga Fernández Arconada</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Hospital General Yagüe</s1>
<s2>Burgos</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<wicri:noRegion>Burgos</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Trejo Gabriel Y Galan, Jose Maria" sort="Trejo Gabriel Y Galan, Jose Maria" uniqKey="Trejo Gabriel Y Galan J" first="José Maria" last="Trejo Gabriel Y Galan">José Maria Trejo Gabriel Y Galan</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, Hospital General Yagüe</s1>
<s2>Burgos</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<wicri:noRegion>Burgos</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Clinical trial</term>
<term>Huntington disease</term>
<term>Nervous system diseases</term>
<term>Placebo</term>
<term>Placebo effect</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Chorée de Huntington</term>
<term>Pathologie du système nerveux</term>
<term>Effet placebo</term>
<term>Essai clinique</term>
<term>Placebo</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Background: Classically, clinical trials are based on the placebo-control design. Our aim was to analyze the placebo effect in Huntington's disease. Methods: Placebo data were obtained from an international, longitudinal, placebo-controlled trial for Huntington's disease (European Huntington's Disease Initiative Study Group). One-hundred and eighty patients were evaluated using the Unified Huntington Disease Rating Scale over 36 months. A placebo effect was defined as an improvement of at least 50% over baseline scores in the Unified Huntington Disease Rating Scale, and clinically relevant when at least 10% of the population met it. Results: Only behavior showed a significant placebo effect, and the proportion of the patients with placebo effect ranged from 16% (first visit) to 41 % (last visit). Nondepressed patients with better functional status were most likely to be placebo-responders over time. Conclusions: In Huntington's disease, behavior seems to be more vulnerable to placebo than overall motor function, cognition, and function.</div>
</front>
</TEI>
<affiliations><list><country><li>Espagne</li>
</country>
<region><li>Communauté de Madrid</li>
</region>
<settlement><li>Madrid</li>
</settlement>
</list>
<tree><country name="Espagne"><noRegion><name sortKey="Cubo, Esther" sort="Cubo, Esther" uniqKey="Cubo E" first="Esther" last="Cubo">Esther Cubo</name>
</noRegion>
<name sortKey="Arconada, Olga Fernandez" sort="Arconada, Olga Fernandez" uniqKey="Arconada O" first="Olga Fernández" last="Arconada">Olga Fernández Arconada</name>
<name sortKey="De Yebenes, Justo Garcia" sort="De Yebenes, Justo Garcia" uniqKey="De Yebenes J" first="Justo Garcia" last="De Yebenes">Justo Garcia De Yebenes</name>
<name sortKey="Del Puerto, Ines" sort="Del Puerto, Ines" uniqKey="Del Puerto I" first="Inés" last="Del Puerto">Inés Del Puerto</name>
<name sortKey="Gonzalez, Miguel" sort="Gonzalez, Miguel" uniqKey="Gonzalez M" first="Miguel" last="Gonzalez">Miguel Gonzalez</name>
<name sortKey="Trejo Gabriel Y Galan, Jose Maria" sort="Trejo Gabriel Y Galan, Jose Maria" uniqKey="Trejo Gabriel Y Galan J" first="José Maria" last="Trejo Gabriel Y Galan">José Maria Trejo Gabriel Y Galan</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001025 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001025 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Exploration |type= RBID |clé= Pascal:12-0198679 |texte= Placebo Effect Characteristics Observed in a Single, International, Longitudinal Study in Huntington's Disease }}
This area was generated with Dilib version V0.6.23. |